Melatonin and its receptors: a new class of sleep-promoting agents.
作者信息
Doghramji Karl
机构信息
Department of Psychiatry and Human Behavior Jefferson Medical College, Philadelphia, PA, USA.
出版信息
J Clin Sleep Med. 2007 Aug 15;3(5 Suppl):S17-23.
Abstract
摘要
相似文献
1
Melatonin and its receptors: a new class of sleep-promoting agents.褪黑素及其受体：一类新型促眠剂。
J Clin Sleep Med. 2007 Aug 15;3(5 Suppl):S17-23.
2
[Melatonin receptor agonist].[褪黑素受体激动剂]
Nihon Rinsho. 2015 Jun;73(6):1017-22.
3
Role of melatonin in the regulation of human circadian rhythms and sleep.褪黑素在调节人体昼夜节律和睡眠中的作用。
J Neuroendocrinol. 2003 Apr;15(4):432-7. doi: 10.1046/j.1365-2826.2003.00989.x.
4
Musing about melatonin and sleep: it's all about timing.关于褪黑素与睡眠的思考：一切都关乎时间安排。
Sleep. 2006 May;29(5):606-7. doi: 10.1093/sleep/29.5.606.
5
The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: a preliminary study.外源性褪黑素对慢性失眠症患者总睡眠时间和日间警觉性的影响：一项初步研究。
Biol Psychiatry. 1991 Aug 15;30(4):371-6. doi: 10.1016/0006-3223(91)90293-u.
6
[Melatonin as a regulator of human sleep and circadian systems].[褪黑素作为人类睡眠和昼夜节律系统的调节因子]
Nihon Rinsho. 2012 Jul;70(7):1139-44.
7
Let there be sleep--on time.按时入睡。
Lancet. 2009 Feb 7;373(9662):439-41. doi: 10.1016/S0140-6736(08)61813-9. Epub 2008 Dec 4.
8
Potential action of melatonin in insomnia.褪黑素在失眠症中的潜在作用。
Sleep. 2003 Dec 15;26(8):1058-9.
9
Melatonin for the treatment of disorders in circadian rhythm and sleep: could it form a basis for medication?褪黑素用于治疗昼夜节律和睡眠障碍：它能成为药物治疗的基础吗？
Recept Channels. 2003;9(6):379-85. doi: 10.3109/714041018.
10
Fluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profile.
Arch Gen Psychiatry. 2000 Aug;57(8):812-3. doi: 10.1001/archpsyc.57.8.812.
引用本文的文献
1
MT2 receptor mediates melatonin-induced thermogenic program in human myoblasts: insights for circadian syndrome and diabesity treatment.MT2受体介导褪黑素诱导人成肌细胞的产热程序：对昼夜节律综合征和糖尿病肥胖症治疗的启示
Front Pharmacol. 2025 Jul 8;16:1633326. doi: 10.3389/fphar.2025.1633326. eCollection 2025.
2
Chrononutrition: Potential, Challenges, and Application in Managing Obesity.时间营养学：在管理肥胖症方面的潜力、挑战及应用
Int J Mol Sci. 2025 May 26;26(11):5116. doi: 10.3390/ijms26115116.
3
Integrative sleep management: from molecular pathways to conventional and herbal treatments.综合睡眠管理：从分子途径到传统与草药治疗
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 8. doi: 10.1007/s00210-025-04183-y.
4
Circadian Regulation in Diurnal Mammals: Neural Mechanisms and Implications in Translational Research.昼行性哺乳动物的昼夜节律调节：神经机制及其在转化研究中的意义
Biology (Basel). 2024 Nov 22;13(12):958. doi: 10.3390/biology13120958.
5
Melatonin's Impact on Wound Healing.褪黑素对伤口愈合的影响。
Antioxidants (Basel). 2024 Oct 2;13(10):1197. doi: 10.3390/antiox13101197.
6
Exploring the association between melatonin and nicotine dependence (Review).探讨褪黑素与尼古丁依赖之间的关系（综述）。
Int J Mol Med. 2024 Oct;54(4). doi: 10.3892/ijmm.2024.5406. Epub 2024 Aug 2.
7
Sleep and allergic diseases among young Chinese adults from the Singapore/Malaysia Cross-Sectional Genetic Epidemiology Study (SMCGES) cohort.来自新加坡/马来西亚横断面遗传流行病学研究（SMCGES）队列的年轻中国成年人的睡眠与过敏性疾病。
J Physiol Anthropol. 2024 Jan 30;43(1):6. doi: 10.1186/s40101-024-00356-5.
8
The Role of Circadian Rhythms in Stroke: A Narrative Review.昼夜节律在中风中的作用：综述。
Neurochem Res. 2024 Feb;49(2):290-305. doi: 10.1007/s11064-023-04040-5. Epub 2023 Oct 14.
9
Melatonin attenuates chronic sleep deprivation-induced cognitive deficits and HDAC3-Bmal1/clock interruption.褪黑素可减轻慢性睡眠剥夺引起的认知功能障碍和 HDAC3-Bmal1/时钟中断。
CNS Neurosci Ther. 2024 Mar;30(3):e14474. doi: 10.1111/cns.14474. Epub 2023 Sep 18.
10
Insomnia and circadian rhythm: a bibliometrics study and visualization analysis CiteSpace.失眠与昼夜节律：一项文献计量学研究及可视化分析 CiteSpace
Front Neurol. 2023 Jun 15;14:1184302. doi: 10.3389/fneur.2023.1184302. eCollection 2023.
本文引用的文献
1
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.雷美替胺治疗慢性失眠症患者的疗效和安全性评估。
J Clin Sleep Med. 2007 Aug 15;3(5):495-504.
2
Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.雷美替胺：一种新型催眠药，无滥用倾向且无镇静副作用。
Arch Gen Psychiatry. 2006 Oct;63(10):1149-57. doi: 10.1001/archpsyc.63.10.1149.
3
Genetics of the sleep-wake cycle and its disorders.睡眠-觉醒周期及其障碍的遗传学
Metabolism. 2006 Oct;55(10 Suppl 2):S7-12. doi: 10.1016/j.metabol.2006.07.006.
4
Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.雷美替胺对老年慢性失眠患者自述睡眠潜伏期的影响。
Sleep Med. 2006 Jun;7(4):312-8. doi: 10.1016/j.sleep.2006.01.003. Epub 2006 May 18.
5
Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia.雷美替胺是一种高亲和力的MT1和MT2褪黑素受体激动剂，适用于治疗失眠，其单次递增剂量的处置动力学和耐受性研究。
J Clin Pharmacol. 2006 Feb;46(2):140-8. doi: 10.1177/0091270005283461.
6
The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis.外源性褪黑素治疗原发性睡眠障碍的疗效与安全性：一项荟萃分析。
J Gen Intern Med. 2005 Dec;20(12):1151-8. doi: 10.1111/j.1525-1497.2005.0243.x.
7
The human circadian system in normal and disordered sleep.正常睡眠和睡眠障碍中的人体昼夜节律系统。
J Clin Psychiatry. 2005;66 Suppl 9:3-9; quiz 42-3.
8
An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.雷美替胺治疗慢性原发性失眠患者的疗效、安全性及剂量反应研究。
Sleep Med. 2006 Jan;7(1):17-24. doi: 10.1016/j.sleep.2005.09.004. Epub 2005 Nov 23.
9
Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men.在健康老年男性中，傍晚早期给予褪黑素激动剂阿戈美拉汀后激素释放和体温24小时节律的相移。
Clin Endocrinol (Oxf). 2005 Sep;63(3):298-304. doi: 10.1111/j.1365-2265.2005.02341.x.
10
The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.褪黑素激动剂β-甲基-6-氯褪黑素治疗原发性失眠的疗效和安全性：一项随机、安慰剂对照、交叉临床试验
J Clin Psychiatry. 2005 Mar;66(3):384-90. doi: 10.4088/jcp.v66n0316.
Zotero 插件